CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5566.7M
Enterprise Value 3378.39M
Trailing P/E N/A
Forward P/E 1-8.49
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)13.22
Price/Book (mrq)37.04
Enterprise Value/Revenue 38.82
Enterprise Value/EBITDA 6-9.52

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin -88.55%
Operating Margin (ttm)-93.92%

Management Effectiveness

Return on Assets (ttm)-13.51%
Return on Equity (ttm)-80.77%

Income Statement

Revenue (ttm)42.88M
Revenue Per Share (ttm)0.86
Quarterly Revenue Growth (yoy)-83.40%
Gross Profit (ttm)N/A
EBITDA -39.76M
Net Income Avi to Common (ttm)-37.97M
Diluted EPS (ttm)-0.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)176.98M
Total Cash Per Share (mrq)3.37
Total Debt (mrq)19.69M
Total Debt/Equity (mrq)133.59
Current Ratio (mrq)2.82
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)16.44M
Levered Free Cash Flow (ttm)64.17M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.47
52-Week Change 3-27.72%
S&P500 52-Week Change 34.04%
52 Week High 315.08
52 Week Low 39.07
50-Day Moving Average 311.02
200-Day Moving Average 311.08

Share Statistics

Avg Vol (3 month) 3321.19k
Avg Vol (10 day) 3297.2k
Shares Outstanding 552.57M
Float 28.59M
% Held by Insiders 138.13%
% Held by Institutions 153.25%
Shares Short (Feb 28, 2019) 41.17M
Short Ratio (Feb 28, 2019) 43.22
Short % of Float (Feb 28, 2019) 44.70%
Short % of Shares Outstanding (Feb 28, 2019) 42.24%
Shares Short (prior month Jan 31, 2019) 41.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A